Stocks making the biggest moves midday: Nike, Rent-A-Center, Carnival Cruise


People walk near the entrance to Nike store, May 25, 2022 in Moscow, Russia.

Konstantin Zavrazhin | Getty Images News | Getty Images

Check out the companies making headlines in midday trading.

Nike — Nike shares dropped 12.8% after the sneaker giant said Thursday its inventory was overstocked, up 44% in its latest quarter. As a result it will offer more discounts to clear out the excess merchandise. Other retailers were also dragged down, with Lululemon Athletica and Under Armour losing almost 6% and nearly 5% respectively.

Rent-A-Center — Shares of Rent-A-Center slipped 21.6% after the company slashed its current-quarter earnings guidance, saying that economic conditions have weighed on consumer traffic and payment patterns.

Carnival Cruise — Shares of Carnival Cruise plunged 23.3% after the company forecast a loss for the fourth quarter, saying high fuel prices and inflation will delay its return to profitability. Royal Caribbean and Norwegian Cruise Lines also slipped, falling 13% and 18%, respectively.

Micron — Shares of Micron rose 1.7% after the company reported quarterly earnings that beat Wall Street expectations, even though sales fell. The chipmaker also gave a weaker-than-expected revenue outlook, saying sales are being hit by slowing consumer demand.

Charles River Laboratories — Charles River shares rose 3.6% after Jefferies upgraded the stock to buy from hold, citing the company’s potential in animal studies.

Twitter — Shares of Twitter rose 2.6% after texts between its founder, Jack Dorsey, and Elon Musk were released in court filings. The Tesla CEO is embroiled in a legal battle over his bid to buy the social media company.

Nucor — Shares of steel company Nucor jumped 1.6% after it announced plans to spend $425 million expanding a galvanized steel line at its South Carolina plant.

Amylyx Pharmaceuticals — Shares of the pharmaceutical company dropped 6.8% despite the stock rallying after hours Thursday on news of the Food and Drug Administration approving its controversial Lou Gehrig’s disease drug.

Generac — Shares of Generac gained 2.3% after Cowen initiated coverage of the company with a buy rating. The generator company is a clear industry winner and has value in its solar offering.

— CNBC’s Alex Harring and Michelle Fox contributed reporting.



Source link

Related articles

Mihaly Csikszentmihalyi spent many years learning hundreds of individuals on the moments they felt most deeply alive, and their solutions stored pointing to the...

Mihaly Csikszentmihalyi didn't discover the deepest type of human aliveness the place trendy tradition typically tells us to search for it. Not in whole consolation. Not in passive ease. Not within the clean...

Market Construction by TradingLabs ID – Buying and selling Methods – 11 July 2026

Grasp Tape Studying with the Final Market Construction Indicator for MT4 and MT5 Welcome to a brand new period of chart readability. In...

This ransomware negotiator was paid to battle hackers, he was secretly working with them as a substitute

WTF?! Federal prosecutors say a ransomware negotiator exploited the very channels used to handle cyberattacks, turning delicate breach information into leverage for the hackers he was speculated to battle. That...

My Fitbit Air take a look at revealed the failings of calorie counting with a well being tracker – this is why

Polar H10 Chest Strap Fitbit Air Absolute Distinction% DistinctionEnergy burned152 kcal 105 kcal- 47 kcal -30.90%Avg. coronary heart price 100 bpm101 bpm1 bpm 1%Min. coronary heart price 66 bpm 67...

IEA chief urges EU to revisit Arctic oil and fuel drilling ban

(Bloomberg) – Worldwide Power Company Govt Director Fatih Birol pressed the European Union to revisit its moratorium on drilling for oil and fuel within the Arctic, difficult the bloc’s long-held opposition to new...
spot_img

Latest articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

WP2Social Auto Publish Powered By : XYZScripts.com